Back to Archived Journals » Botanics: Targets and Therapy » Volume 3

Antioxidant and hepatoprotective effects of Garcinia indica fruit rind in antitubercular drug-induced liver injury in rats

Authors Panda V, Ashar H, Sharan A

Received 7 January 2013

Accepted for publication 25 February 2013

Published 27 March 2013 Volume 2013:3 Pages 29—37


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Vandana S Panda,1 Hardik D Ashar,1 Anita Sharan2

1Department of Pharmacology and Toxicology, Prin KM Kundnani College of Pharmacy, Colaba, Mumbai, India; 2Department of Pathology, Dr DY Patil Medical College, Nerul, Navi Mumbai, India

Abstract: The protective effects of aqueous extracts of the fruit rind of Garcinia indica (GIE) in antitubercular drug (ATD)-induced liver injury were investigated in rats. GIE (400 mg/kg and 800 mg/kg) and the reference drug Liv.52 (500 mg/kg) were administered orally for 29 days to ATD (isoniazid 7.5 mg/kg, rifampicin 10 mg/kg, and pyrazinamide 35 mg/kg)-treated rats. GIE attenuated significantly the ATD-elevated levels of aspartate aminotransferase, alanine transaminase, alkaline phosphatase, bilirubin, and malondialdehyde and restored the ATD-depleted levels of glutathione (GSH), superoxide dismutase, catalase, GSH peroxidase, and GSH reductase. The present findings indicate that the hepatoprotective effect of GIE in ATD-induced oxidative damage may be due to its antioxidant activity.

Keywords: Garcinia indica fruit, antitubercular drugs, Liv.52, hepatoprotective, antioxidant activity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.